Open6.200 | Close5.710 |
Vol / Avg.37.379K / 17.587K | Mkt Cap15.916M |
Day Range5.600 - 6.200 | 52 Wk Range3.550 - 56.720 |
Kala Bio Stock (NASDAQ: KALA) stock price, news, charts, stock research, profile.
Open6.200 | Close5.710 |
Vol / Avg.37.379K / 17.587K | Mkt Cap15.916M |
Day Range5.600 - 6.200 | 52 Wk Range3.550 - 56.720 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.150 | -3.410 | -1.2600 | ||||
REV | 830.000K | 0 | -830.000K |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -3.190 | -4.360 | -1.1700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-17 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Lowers | 24.00 | 22.00 |
2023-08-11 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 24.00 |
2023-05-10 | HC Wainwright & Co. | Yi Chen | Reiterates | Buy | Raises | 22.00 | 24.00 |
2023-05-01 | HC Wainwright & Co. | Yi Chen | Reiterates | Buy | Maintains | - | 22.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
KALA | Kala Bio | -1.17% | 15.9M |
VINC | Vincerx Pharma | 10.75% | 15.2M |
GLTO | Galecto | -0.02% | 16.3M |
IMPL | Impel Pharmaceuticals | -10.7% | 12.8M |
TTOO | T2 Biosystems | -3.51% | 14.5M |
You can purchase shares of Kala Bio (NASDAQ: KALA) through any online brokerage.
Other companies in Kala Bio’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Impel Pharmaceuticals (NASDAQ:IMPL), T2 Biosystems (NASDAQ:TTOO) and Sensei Biotherapeutics (NASDAQ:SNSE).
The latest price target for Kala Bio (NASDAQ: KALA) was reported by HC Wainwright & Co. on Friday, November 17, 2023. The analyst firm set a price target for 22.00 expecting KALA to rise to within 12 months (a possible 272.25% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Kala Bio (NASDAQ: KALA) is $5.91 last updated November 29, 2023 at 11:40 PM UTC.
There is no dividend information for Kala Bio.
Kala Bio’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Kala Bio.
Kala Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.